Effects of clofibrate with androsterone (atromid) and without androsterone (atromid-S) on blood platelets and lipids in ischaemic heart disease.
作者信息
Carson P, McDonald L, Pickard S, Pilkington T, Davies B, Love F
出版信息
Br Heart J. 1966 May;28(3):400-3. doi: 10.1136/hrt.28.3.400.
Abstract
摘要
相似文献
1
Effects of clofibrate with androsterone (atromid) and without androsterone (atromid-S) on blood platelets and lipids in ischaemic heart disease.安妥明与雄酮（安妥明）及不含雄酮（安妥明-S）对缺血性心脏病患者血小板及血脂的影响。
Br Heart J. 1966 May;28(3):400-3. doi: 10.1136/hrt.28.3.400.
2
[CHOLESTEROL AND BLOOD LIPID BEHAVIOR IN ARTERIOSCLEROSIS UNDER THE EFFECTS OF PROTECTED ANDROSTERONE (ATROMID)].[受保护雄酮（安妥明）作用下动脉粥样硬化中胆固醇及血脂的行为]
Rev Esp Cardiol. 1964 Jul;17:563-73.
3
A comparison of platelet stickiness tests during an atromid-S trial.安妥明（Atromid-S）试验期间血小板黏附试验的比较。
Thromb Diath Haemorrh. 1966 Dec 1;16(3):768-77.
4
[Effect of Atromid on blood lipids in patients with hyperlipemia].[安妥明对高脂血症患者血脂的影响]
Ter Arkh. 1968 Mar;40(3):15-20.
5
THE EFFECT OF ATROMID AND ATROMID-S ON PLASMA FIBRINOGEN AND PLASMINOGEN LEVELS.安妥明及安妥明-S对血浆纤维蛋白原和纤溶酶原水平的影响
Curr Ther Res Clin Exp. 1965 Aug;7:437-42.
6
THE EFFECT OF ATROMID-S ON THE FIBRINOLYTIC ENZYME SYSTEM.安妥明对纤维蛋白溶解酶系统的作用。
J Atheroscler Res. 1965 May-Jun;5(3):347-50. doi: 10.1016/s0368-1319(65)80052-7.
7
A TWO-YEAR EVALUATION OF "ATROMID" FOR THE CONTROL OF ABNORMAL BLOOD LIPID LEVELS.“安妥明”控制血脂异常的两年评估
Med J Aust. 1965 Jul 31;2(5):192-4.
8
EFFECT OF ATROMID ON PLATELET STICKINESS.安妥明对血小板黏附性的影响。
J Atheroscler Res. 1963 Sep-Dec;3:619-22. doi: 10.1016/s0368-1319(63)80044-7.
9
Atromid-S for the reduction of plasma lipids.安妥明用于降低血脂。
Med Lett Drugs Ther. 1967 Jun 16;9(12):45-7.
10
THE EFFECT OF ATROMID ON SERUM LIPIDS AND COAGULATION ACTIVITY.安妥明对血脂及凝血活性的影响。
J Atheroscler Res. 1963 Sep-Dec;3:571-9. doi: 10.1016/s0368-1319(63)80040-x.
引用本文的文献
1
Thrombosis in coronary heart disease.冠心病中的血栓形成
Br Heart J. 1968 Mar;30(2):151-67. doi: 10.1136/hrt.30.2.151.
2
Trial of clofibrate.氯贝丁酯试验。
Br Med J. 1972 Jan 22;1(5794):247. doi: 10.1136/bmj.1.5794.247-a.
本文引用的文献
1
A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity.一种估算血清总胆固醇的简化方法及其特异性验证。
J Biol Chem. 1952 Mar;195(1):357-66.
2
Morphology and enumeration of human blood platelets.人体血小板的形态学与计数
J Appl Physiol. 1950 Dec;3(6):365-77. doi: 10.1152/jappl.1950.3.6.365.
3
Reduction of serum-lipid and uric-acid levels by an orally active androsterone.口服活性雄甾酮降低血清脂质和尿酸水平
Lancet. 1962 Jun 23;1(7243):1321-3. doi: 10.1016/s0140-6736(62)92422-4.
4
EFFECT OF ETHYL CHLOROPHENOXYISOBUTYRATE WITH OR WITHOUT ANDROSTERONE ON PLATELET STICKINESS.氯苯氧异丁酸乙酯（无论有无雄酮）对血小板黏附性的影响。
Lancet. 1964 Aug 1;2(7353):233-4. doi: 10.1016/s0140-6736(64)90184-9.
5
SOME EFFECTS OF ATROMID ON PLATELET ECONOMY AND BLOOD COAGULATION IN MAN.祛脂乙酯对人体血小板代谢及血液凝固的某些作用
J Atheroscler Res. 1963 Sep-Dec;3:623-33. doi: 10.1016/s0368-1319(63)80045-9.
6
EFFECT OF ATROMID ON PLATELET STICKINESS.安妥明对血小板黏附性的影响。
J Atheroscler Res. 1963 Sep-Dec;3:619-22. doi: 10.1016/s0368-1319(63)80044-7.
7
REDUCTION OF SERUM CHOLESTEROL AND LIPIDS BY ETHYL CHLOROPHENOXYISOBUTYRATE.氯苯丁酯降低血清胆固醇和脂质水平的作用
J Atheroscler Res. 1963 Sep-Dec;3:454-66. doi: 10.1016/s0368-1319(63)80025-3.
8
Experimental evaluation of an orally active combination of androsterone with ethyl chlorophenoxy-isobutyrate.雄酮与氯苯氧异丁酸乙酯口服活性组合的实验评估。
Lancet. 1962 Jun 23;1(7243):1323-6. doi: 10.1016/s0140-6736(62)92423-6.
9
The role of lipoproteins in coronary disease.脂蛋白在冠心病中的作用。
Bull Schweiz Akad Med Wiss. 1957 Apr;13(1-4):152-78.
Zotero 插件